Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)

NCT00953771 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped low enrollment

Conditions

Thrombotic Thrombocytopenic Purpura

Interventions

DRUG: Danazol

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]